HIMSS TV

Intermountain Health CISO Erik Decker talks about the SMART toolkit, which identifies critical healthcare functions so leaders can plan ways to keep their organizations running in case of cyberattacks.

Dr. Amit Zabtani, an orthopedic surgeon at UCLA and cofounder and CMO of CustoMED, says the company uses 3D printing to create patient-specific instruments based on an individual’s anatomy, enabling more precise positioning during surgery.

According to Clearwater's Jackie Mattingly, sustainable cybersecurity funding for rural hospitals remains elusive, with many states allocating little to no Rural Health Transformation Program money to security.

Debra Beauregard, director of medical intelligence and innovation at Rady Children’s Health, discusses why some hospitals are cautious about exploring new technologies and how her team evaluates technology solutions to pilot and scale.

CEO of Lirio, Marten den Haring, explains how the company uses its proprietary Large Behavior Model to understand a person’s health behaviors, motivations and decision-making patterns to drive personalized patient engagement in healthcare.

Sergio Calvo, general manager of theranostics at GE HealthCare, discusses the organization's use of theranostics in cancer care and how the technology combines targeted therapy with diagnostic imaging for personalized oncology care.

As medical practices seek to implement agentic AI, Michael Clark, OnPoint Healthcare Partners president, recommends constant oversight to ensure agents' work is repeatable, auditable and traceable by a clinical advisory team.

Alexander Richter, executive director and head of the SciTech Innovation Hub at SciTech Scity, which recently won the World Economic Forum's 2025 Public-Private Collaboration Award, discusses the selection process for piloting and scaling health tech.

Lakewood Health System's Jim Roeder says building regional alliances enables rural hospitals to share expertise, strengthen defenses and keep care available when cyber incidents happen.

The CEO of NeuroOne, Dave Rosa, discusses the company's minimally invasive brain-computer interface thin-film, flexible electrode technology, its successes in patients with seizures and the potential benefits across a range of neurological conditions.